Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy
about
A qualitative systematic review of factors influencing parents' vaccination decision-making in the United KingdomComprehensive control of human papillomavirus infections and related diseasesAssessment of high-risk human papillomavirus infections using clinician- and self-collected cervical sampling methods in rural women from far western Nepal.[SUS users' knowledge of and attitude to HPV virus and vaccines available in Brazil]Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.HPV Prevention series.Dynamics of high-risk nonvaccine human papillomavirus types after actual vaccination scheme.The road ahead for cervical cancer prevention and control.Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda.The current position and the future perspectives of cervical cancer screening.The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs.HPV-based cervical cancer screening- facts, fiction, and misperceptions.Triage of high-risk HPV positive women in cervical cancer screening.Clinical characteristics of women diagnosed with carcinoma who tested positive for cervical and anal high-risk human papillomavirus DNA and E6 RNA.Human Papillomavirus Vaccination: Making Sense of the Public Controversy
P2860
Q28077190-037AE272-4CA6-4092-98B2-E5CFEA6C4C1EQ33772648-2157D285-F214-4DBC-979B-0472E7A0F256Q33825915-8CE70747-889C-4241-8CC6-057C7ED07505Q34386419-9ACC01AC-945B-42C5-912E-816FD71D1CB6Q36108910-220331F8-765B-4611-B7D1-BA2B950DA5B0Q36561092-3232C4A6-A1A2-4474-9228-4039398D50C3Q37718767-DD3806D8-C558-4768-9721-9A18F2716960Q37719631-853BCFAA-B0EA-4BA4-BBF2-8F309486EA48Q37846447-2EA2F87D-A914-45C1-B5DE-D27D4B110EECQ38168923-04D2DE45-090C-4FF7-958A-F7CAE28ADABAQ38254337-D1C66164-1571-4684-98EE-0BE47779BEB3Q38255277-AF51454C-6E3E-48B2-8BA6-4D953DBF7501Q38372386-25C0CD9C-7311-406A-B29F-509EEBC2A1E2Q38824019-D749C88C-D2C8-4C9D-87DD-0FE3E835C309Q41485873-7DEABD32-62AC-4301-832D-759F2AA2C11DQ57089326-7CD64FF9-7F88-44DB-B87C-E8C5C4B192C3
P2860
Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Human papillomavirus and cance ...... research, policy, and advocacy
@ast
Human papillomavirus and cance ...... research, policy, and advocacy
@en
Human papillomavirus and cance ...... research, policy, and advocacy
@nl
type
label
Human papillomavirus and cance ...... research, policy, and advocacy
@ast
Human papillomavirus and cance ...... research, policy, and advocacy
@en
Human papillomavirus and cance ...... research, policy, and advocacy
@nl
prefLabel
Human papillomavirus and cance ...... research, policy, and advocacy
@ast
Human papillomavirus and cance ...... research, policy, and advocacy
@en
Human papillomavirus and cance ...... research, policy, and advocacy
@nl
P2093
P2860
P3181
P1433
P1476
Human papillomavirus and cance ...... research, policy, and advocacy
@en
P2093
Eduardo L. Franco
Margaret A. Stanley
Myriam Chevarie-Davis
Sandra D. Isidean
Thomas R. Broker
P2860
P304
P3181
P356
10.1016/J.VACCINE.2012.06.092
P407
P478
30 Suppl 5
P577
2012-11-20T00:00:00Z